Cubist Systematic Strategies, LLC - AMNEAL PHARMACEUTICALS INC ownership

AMNEAL PHARMACEUTICALS INC's ticker is AMRX and the CUSIP is 03168L105. A total of 156 filers reported holding AMNEAL PHARMACEUTICALS INC in Q3 2022. The put-call ratio across all filers is 0.47 and the average weighting 0.0%.

Quarter-by-quarter ownership
Cubist Systematic Strategies, LLC ownership history of AMNEAL PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$1,017
-97.7%
241
-99.2%
0.00%
Q1 2023$43,494
-66.3%
31,291
-51.8%
0.00%
-100.0%
Q4 2022$129,179
-52.3%
64,914
-51.7%
0.00%
-50.0%
Q3 2022$271,000
+652.8%
134,404
+1075.5%
0.00%
Q2 2022$36,000
-45.5%
11,434
-27.8%
0.00%
-100.0%
Q1 2022$66,000
-74.0%
15,830
-70.1%
0.00%
-50.0%
Q4 2021$254,000
-47.4%
53,001
-41.5%
0.00%
-66.7%
Q3 2021$483,000
+158.3%
90,538
+147.8%
0.01%
+200.0%
Q2 2021$187,000
-90.4%
36,542
-87.4%
0.00%
-92.0%
Q1 2021$1,954,000
+784.2%
290,296
+499.7%
0.02%
+733.3%
Q4 2020$221,000
-41.8%
48,410
-50.5%
0.00%
-50.0%
Q3 2020$380,000
-37.5%
97,894
-23.4%
0.01%
-45.5%
Q2 2020$608,000
+744.4%
127,778
+516.3%
0.01%
+450.0%
Q1 2020$72,000
-37.9%
20,732
-13.6%
0.00%0.0%
Q4 2019$116,000
-38.0%
24,004
-62.7%
0.00%
-50.0%
Q3 2019$187,000
-84.4%
64,398
-61.4%
0.00%
-81.8%
Q2 2019$1,196,000
+483.4%
166,747
+1050.1%
0.02%
+214.3%
Q1 2019$205,000
-78.2%
14,498
-79.1%
0.01%
-84.1%
Q4 2018$939,000
-57.9%
69,397
-31.0%
0.04%
-63.9%
Q3 2018$2,232,000
+225.8%
100,604
+141.2%
0.12%
+258.8%
Q2 2018$685,00041,7130.03%
Other shareholders
AMNEAL PHARMACEUTICALS INC shareholders Q3 2022
NameSharesValueWeighting ↓
Fosun International Ltd 21,521,301$102,442,0009.84%
TPG Group Holdings (SBS) Advisors, Inc. 16,213,367$77,176,0001.36%
Sivik Global Healthcare LLC 600,000$2,856,0000.95%
THB ASSET MANAGEMENT 651,150$3,099,0000.90%
Eversept Partners, LP 886,587$4,220,1540.58%
Spark Investment Management LLC 30,100$143,0000.52%
GLOBEFLEX CAPITAL L P 240,680$1,146,0000.29%
Alambic Investment Management, L.P. 19,493$93,0000.23%
GSA CAPITAL PARTNERS LLP 49,901$238,0000.13%
C M BIDWELL & ASSOCIATES LTD 29,550$141,0000.13%
View complete list of AMNEAL PHARMACEUTICALS INC shareholders